Guanfacine

How Hard Is It to Find Guanfacine in Stock?

As of 2026, Guanfacine is not on the FDA's active drug shortage list. Generic Guanfacine is manufactured by multiple companies, providing supply redundancy. Overall national availability is good. However, localized pharmacy-level stock-outs occur — especially for higher-strength ER tablets (3 mg and 4 mg) — partly due to increased demand from patients who have been switched from stimulant medications during the ongoing ADHD stimulant shortage.

Guanfacine IR (1 mg and 2 mg) is widely available and rarely presents availability issues. Guanfacine ER at lower strengths (1 mg, 2 mg) is generally consistently stocked; the 3 mg and 4 mg strengths are ordered less frequently and may require more pharmacy calls. Independent pharmacies often have more sourcing flexibility than chain pharmacies for these less-common strengths.

If you're having trouble finding Guanfacine in stock, medfinder can contact pharmacies near you to identify which ones have your specific strength available. This saves hours of phone calls and helps ensure you never run out of this medication, which should never be stopped abruptly.

Who Can Prescribe Guanfacine?

Guanfacine is not a controlled substance, so any licensed prescriber can legally write a prescription for it without special DEA registration or controlled substance limitations. This makes it widely accessible through a variety of provider types.

Psychiatrists — most common for adult ADHD and complex pediatric cases

Pediatricians — frequently manage ADHD in children 6–17 including Guanfacine ER prescribing

Primary Care Physicians (PCPs) / Family Medicine — can prescribe for both ADHD and hypertension

Neurologists — may prescribe for ADHD, Tourette syndrome, and tic disorders

Nurse Practitioners (NPs) and Physician Assistants (PAs) — can independently prescribe in most states without restriction

Because Guanfacine is non-controlled, telehealth prescribing is available without any in-person visit requirement. This makes it significantly more accessible than stimulant ADHD medications. Telehealth platforms including Done, Cerebral, Talkiatry, and general platforms (Teladoc, MDLive) can prescribe Guanfacine for appropriate patients.

Is Guanfacine a Controlled Substance?

No. Guanfacine is not a DEA-scheduled controlled substance. Unlike stimulant ADHD medications (Adderall, Ritalin — Schedule II), Guanfacine has no known abuse potential or dependency risk and is not subject to DEA production quotas or controlled substance dispensing restrictions.

Practical implications of non-controlled status: Guanfacine can be prescribed via telehealth without requiring an in-person visit first. Prescribers can write 90-day supplies. There are no limits on the number of refills, and the prescription can be transferred between pharmacies. Mail-order fulfillment is straightforward and unrestricted. This makes Guanfacine significantly easier to access than Schedule II stimulant medications.

Note: While Guanfacine itself is not controlled, it should never be stopped abruptly. Sudden discontinuation can cause rebound hypertension, anxiety, and elevated heart rate. Always follow your prescriber's guidance when discontinuing.

Common Side Effects of Guanfacine

The most frequently reported side effects of Guanfacine in clinical trials include:

Somnolence (sleepiness) — most common, especially when starting or increasing dose

Fatigue — often improves after 2–4 weeks on a stable dose

Headache

Abdominal pain / stomach upset

Dry mouth

Constipation

Dizziness or lightheadedness (orthostatic hypotension)

Low blood pressure (hypotension)

Bradycardia (slow heart rate)

Serious side effects requiring prompt medical attention:

Fainting (syncope)

Very slow or irregular heartbeat

Severe allergic reaction (hives, difficulty breathing, swelling)

Rebound hypertension (if stopped abruptly) — seek immediate medical care

Severe skin rash or skin peeling

Final Thoughts on Guanfacine

Guanfacine is an effective, well-established non-stimulant medication for ADHD and hypertension with a generally favorable availability profile in 2026. It is not subject to the DEA production quotas that have contributed to stimulant shortages, and generic availability from multiple manufacturers means nationwide supply is stable. Patients may encounter localized pharmacy stock-outs, particularly for higher-strength ER formulations, but these are typically manageable with proactive planning.

The most important safety consideration with Guanfacine is that it must never be stopped abruptly. Rebound hypertension is a real and potentially dangerous risk. Patients should always maintain at least a week's supply in advance and have a plan in place if their usual pharmacy runs out.

For cost, generic Guanfacine ER is available for under $10–$15 per month with discount cards, making it one of the more affordable ADHD medications available. If you need help locating it in stock at a pharmacy near you, medfinder can do the searching for you.